142 related articles for article (PubMed ID: 10613832)
1. Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas.
Higashitsuji H; Itoh K; Nagao T; Dawson S; Nonoguchi K; Kido T; Mayer RJ; Arii S; Fujita J
Nat Med; 2000 Jan; 6(1):96-9. PubMed ID: 10613832
[TBL] [Abstract][Full Text] [Related]
2. Gankyrin Promotes Tumor-Suppressor Protein Degradation to Drive Hepatocyte Proliferation.
D'Souza AM; Jiang Y; Cast A; Valanejad L; Wright M; Lewis K; Kumbaji M; Shah S; Smithrud D; Karns R; Shin S; Timchenko N
Cell Mol Gastroenterol Hepatol; 2018; 6(3):239-255. PubMed ID: 30109252
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a small-molecule binder of the oncoprotein gankyrin that modulates gankyrin activity in the cell.
Chattopadhyay A; O'Connor CJ; Zhang F; Galvagnion C; Galloway WR; Tan YS; Stokes JE; Rahman T; Verma C; Spring DR; Itzhaki LS
Sci Rep; 2016 Apr; 6():23732. PubMed ID: 27046077
[TBL] [Abstract][Full Text] [Related]
4. The study of pH-dependent stability shows that the TPLH-mediated hydrogen-bonding network is important for the conformation and stability of human gankyrin.
Yuan C; Guo Y; Zhu L; Guo W; Mahajan A; Weghorst CM; Li J
Biochemistry; 2013 Jul; 52(28):4848-57. PubMed ID: 23777370
[TBL] [Abstract][Full Text] [Related]
5. Erratum: Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinoma.
Hepatology; 2024 May; 79(5):E150-E151. PubMed ID: 38630117
[No Abstract] [Full Text] [Related]
6. The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53.
Higashitsuji H; Higashitsuji H; Itoh K; Sakurai T; Nagao T; Sumitomo Y; Masuda T; Dawson S; Shimada Y; Mayer RJ; Fujita J
Cancer Cell; 2005 Jul; 8(1):75-87. PubMed ID: 16023600
[TBL] [Abstract][Full Text] [Related]
7. The crystal structure of gankyrin, an oncoprotein found in complexes with cyclin-dependent kinase 4, a 19 S proteasomal ATPase regulator, and the tumor suppressors Rb and p53.
Krzywda S; Brzozowski AM; Higashitsuji H; Fujita J; Welchman R; Dawson S; Mayer RJ; Wilkinson AJ
J Biol Chem; 2004 Jan; 279(2):1541-5. PubMed ID: 14573599
[TBL] [Abstract][Full Text] [Related]
8. The oncoprotein p28GANK establishes a positive feedback loop in β-catenin signaling.
Dong LW; Yang GZ; Pan YF; Chen Y; Tan YX; Dai RY; Ren YB; Fu J; Wang HY
Cell Res; 2011 Aug; 21(8):1248-61. PubMed ID: 21691299
[TBL] [Abstract][Full Text] [Related]
9. PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression.
Luo T; Fu J; Xu A; Su B; Ren Y; Li N; Zhu J; Zhao X; Dai R; Cao J; Wang B; Qin W; Jiang J; Li J; Wu M; Feng G; Chen Y; Wang H
Autophagy; 2016 Aug; 12(8):1355-71. PubMed ID: 25905985
[TBL] [Abstract][Full Text] [Related]
10. Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis.
Tian Y; Zhang M; Liu LX; Wang ZC; Liu B; Huang Y; Wang X; Ling YZ; Wang F; Feng X; Tu Y
Front Immunol; 2024; 15():1400744. PubMed ID: 38799446
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of 2,5-substituted pyrimidines as small-molecule gankyrin binders.
Kanabar D; Kane EI; Chavan T; Laflamme TM; Suarez E; Goyal M; Gupta V; Spratt DE; Muth A
Future Med Chem; 2024 Feb; 16(3):239-251. PubMed ID: 38205637
[No Abstract] [Full Text] [Related]
12. Gankyrin inhibits ferroptosis through the p53/SLC7A11/GPX4 axis in triple-negative breast cancer cells.
Lei M; Zhang YL; Huang FY; Chen HY; Chen MH; Wu RH; Dai SZ; He GS; Tan GH; Zheng WP
Sci Rep; 2023 Dec; 13(1):21916. PubMed ID: 38081931
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of a ubiquitin-proteasome system gene signature for prognostic prediction and immune microenvironment evaluation in hepatocellular carcinoma.
Liu ZY; Li YH; Zhang QK; Li BW; Xin L
J Cancer Res Clin Oncol; 2023 Nov; 149(14):13363-13382. PubMed ID: 37490101
[TBL] [Abstract][Full Text] [Related]
14. ANKRD29, as a new prognostic and immunological biomarker of non-small cell lung cancer, inhibits cell growth and migration by regulating MAPK signaling pathway.
Zhao H; Wang Y; He Y; Zhang P; Zeng C; Du T; Shen Q; Zhao S
Biol Direct; 2023 Jun; 18(1):28. PubMed ID: 37277814
[TBL] [Abstract][Full Text] [Related]
15. Gankyrin modulated non-small cell lung cancer progression via glycolysis metabolism in a YAP1-dependent manner.
Yu T; Liu Y; Xue J; Sun X; Zhu D; Ma L; Guo Y; Jin T; Cao H; Chen Y; Zhu T; Li X; Liang H; Du Z; Shan H
Cell Death Discov; 2022 Jul; 8(1):312. PubMed ID: 35810157
[TBL] [Abstract][Full Text] [Related]
16. Second Generation Small Molecule Inhibitors of Gankyrin for the Treatment of Pediatric Liver Cancer.
D'Souza AM; Gnanamony M; Thomas M; Hanley P; Kanabar D; de Alarcon P; Muth A; Timchenko N
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804840
[TBL] [Abstract][Full Text] [Related]
17. Small-Molecule Gankyrin Inhibition as a Therapeutic Strategy for Breast and Lung Cancer.
Kanabar D; Goyal M; Kane EI; Chavan T; Kabir A; Wang X; Shukla S; Almasri J; Goswami S; Osman G; Kokolis M; Spratt DE; Gupta V; Muth A
J Med Chem; 2022 Jul; 65(13):8975-8997. PubMed ID: 35758870
[TBL] [Abstract][Full Text] [Related]
18. Assembly checkpoint of the proteasome regulatory particle is activated by coordinated actions of proteasomal ATPase chaperones.
Nahar A; Sokolova V; Sekaran S; Orth JD; Park S
Cell Rep; 2022 Jun; 39(10):110918. PubMed ID: 35675778
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
